Pharma Journalist 9027 posts 0 comments

AC Immune SA a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced that the first patient has been scanned in a…
Read More...

Nautilus Biotechnology, Inc. a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III, a special…
Read More...

Veru Inc. an oncology biopharmaceutical company, today announced positive efficacy and safety results from a double-blind, randomized, placebo-controlled Phase 2 clinical trial…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of…
Read More...

Merck and BioNTech are further expanding their strategic partnership. Merck, in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and…
Read More...

Moderna, Inc. biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the Singapore Health Sciences Authority (HSA) has approved the interim…
Read More...

AstraZeneca’s Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure…
Read More...

SMi Reports: The 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) will take place for its 5th consecutive year as a virtual conference to explore…
Read More...

A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of…
Read More...

Johnson & Johnson announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for…
Read More...